SARA
GUTIÉRREZ PELAZ
Researcher in the period 2015-2021
Publications (10) SARA GUTIÉRREZ PELAZ publications
2024
-
A proteomic approach supports the clinical relevance of TAT-Cx43266-283 in glioblastoma
Translational Research, Vol. 272, pp. 95-110
2022
-
Src: coordinating metabolism in cancer
Oncogene, Vol. 41, Núm. 45, pp. 4917-4928
2021
-
Efecto del péptido antitumoral TAT-Cx43266-283 en células madre neurales en un modelo de glioma in vivo
VII Jornadas de investigadoras de Castilla y León [Recurso electrónico]: la aventura de la ciencia y la tecnología (Fundación 3CIN), pp. 84
-
Erratum to “Targeting metabolic plasticity in glioma stem cells in vitro and in vivo through specific inhibition of c-Src by TAT-Cx43266-283” [EBioMedicine 62, December 2020] DOI: https://doi.org/10.1016/j.ebiom.2020.103134 (EBioMedicine (2020) 62, (S2352396420305107), (10.1016/j.ebiom.2020.103134))
EBioMedicine
-
Erratum: Connexin43 peptide, TAT-Cx43266-283, selectively targets glioma cells, impairs malignant growth, and enhances survival in mouse models in vivo (Neuro-Oncology DOI: 10.1093/neuonc/noz243)
Neuro-Oncology
-
Impairment of autophagic flux participates in the antitumor effects of tat-cx43266-283 in glioblastoma stem cells
Cancers, Vol. 13, Núm. 17
-
Péptidos penetrantes para atacar al glioma y su microambiente
VII Jornadas de investigadoras de Castilla y León [Recurso electrónico]: la aventura de la ciencia y la tecnología (Fundación 3CIN), pp. 50
2020
-
Connexin43 peptide, TAT-Cx43266-283, selectively targets glioma cells, impairs malignant growth, and enhances survival in mouse models in vivo
Neuro-Oncology, Vol. 22, Núm. 4, pp. 493-504
-
Targeting metabolic plasticity in glioma stem cells in vitro and in vivo through specific inhibition of c-Src by TAT-Cx43266-283
EBioMedicine, Vol. 62